WHAT'S NEW: Since analysts' consensus 2015 revenue and profit estimates for Valeant are below the company's 2015 guidance, any additional "visibility or conviction" regarding the company's results could boost the stock, Cantor analyst Irina Rivkind Koffler stated. Valeant should be able to meet its 2015 guidance, the analyst believes.
http://www.thestreet.com/story/12996852/1/dental-device-makers-seen-as-potential-valeant-vrx-targets.html
http://www.thestreet.com/story/12996852/1/dental-device-makers-seen-as-potential-valeant-vrx-targets.html
No comments:
Post a Comment